Publicaciones en colaboración con investigadores/as de University of Turin (8)

2020

  1. P2Y12 inhibitors in acute coronary syndrome patients with renal dysfunction: an analysis from the RENAMI and BleeMACS projects

    European heart journal. Cardiovascular pharmacotherapy, Vol. 6, Núm. 1, pp. 31-42

  2. The impact of optimal medical therapy on patients with recurrent acute myocardial infarction: Subanalysis from the BleeMACS study

    International Journal of Cardiology, Vol. 318, pp. 1-6

2018

  1. Association of Beta-Blockers with Survival on Patients Presenting with ACS Treated with PCI: A Propensity Score Analysis from the BleeMACS Registry

    American Journal of Cardiovascular Drugs, Vol. 18, Núm. 4, pp. 299-309

2017

  1. Complete or incomplete coronary revascularisation in patients with myocardial infarction and multivessel disease: A propensity score analysis from the "real-life" BleeMACS (Bleeding complications in a Multicenter registry of patients discharged with diagnosis of Acute Coronary Syndrome) registry

    EuroIntervention, Vol. 13, Núm. 4, pp. 407-414

2016

  1. BleeMACS: Rationale and design of the study

    Journal of Cardiovascular Medicine, Vol. 17, Núm. 10, pp. 744-749

  2. Impact of blood transfusion on in-hospital myocardial infarctions according to patterns of acute coronary syndrome: Insights from the BleeMACS registry

    International Journal of Cardiology, Vol. 221, pp. 364-370

  3. Safety and effectiveness of the new P2Y12r inhibitor agents vs clopidogrel in ACS patients according to the geographic area: East Asia vs Europe

    International Journal of Cardiology, Vol. 220, pp. 488-495

2010

  1. Des-acyl ghrelin has specific binding sites and different metabolic effects from ghrelin in cardiomyocytes

    Endocrinology, Vol. 151, Núm. 7, pp. 3286-3298